Subscribe
shutterstock_1486264271_jhvephoto
JHVEphoto / Shutterstock.com
20 July 2021Big PharmaAlex Baldwin

PTAB invalidates Medytox Botox patent

The Patent Trial and Appeal Board (PTAB) has ruled that a Medytox patent for its wrinkle treatment should not have been granted.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Allergan sued for promoting off-label Botox use
20 April 2015   An Ontario-based company has sued Allergan for allegedly infringing a method patent that protects the use of cosmetic drug Botox to treat back pain.
article
USITC to investigate botox imports
3 May 2022   The US International Trade Commission has agreed to investigate imports of botulinum toxin products following a complaint that they infringe trade secrets.
Big Pharma
US appeals court upholds decision on wrinkle treatment
29 June 2023   Board did not violate procedure regarding ‘preliminary guidance’ say Federal Circuit judges | Medytox’s substitute claims found to be ‘unpatentable’.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Americas
Allergan sued for promoting off-label Botox use
20 April 2015   An Ontario-based company has sued Allergan for allegedly infringing a method patent that protects the use of cosmetic drug Botox to treat back pain.
article
USITC to investigate botox imports
3 May 2022   The US International Trade Commission has agreed to investigate imports of botulinum toxin products following a complaint that they infringe trade secrets.
Big Pharma
US appeals court upholds decision on wrinkle treatment
29 June 2023   Board did not violate procedure regarding ‘preliminary guidance’ say Federal Circuit judges | Medytox’s substitute claims found to be ‘unpatentable’.

More on this story

Americas
Allergan sued for promoting off-label Botox use
20 April 2015   An Ontario-based company has sued Allergan for allegedly infringing a method patent that protects the use of cosmetic drug Botox to treat back pain.
article
USITC to investigate botox imports
3 May 2022   The US International Trade Commission has agreed to investigate imports of botulinum toxin products following a complaint that they infringe trade secrets.
Big Pharma
US appeals court upholds decision on wrinkle treatment
29 June 2023   Board did not violate procedure regarding ‘preliminary guidance’ say Federal Circuit judges | Medytox’s substitute claims found to be ‘unpatentable’.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York